Active Stocks Technical Coverage -- Research on Callaway Golf, Annaly Capital Management, Weatherford Intl., and Chelsea Therapeutics Intl.

LONDON, May 21, 2014 /PRNewswire/ --

The markets on Tuesday, May 20, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,374.31, down 0.83% and the NASDAQ Composite closed at 4,096.89, down 0.70%. The S&P 500 edged 0.65% lower, to finish the day at 1,872.83. The losses were broad based as nine out of ten sectors ended the session in negative. During the session, Consumer Discretionary, Industrials and Telecommunication Services sectors ended in negative, while some positive momentum was observed in the Utilities sector. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Callaway Golf Company (NYSE: ELY), Annaly Capital Management Inc. (NYSE: NLY), Weatherford International Ltd (NYSE: WFT) and Chelsea Therapeutics International Ltd (NASDAQ: CHTP). Free technical research on ELY, NLY, WFT and CHTP can be downloaded upon signing up at:
http://www.investor-edge.com/2816-register

On Tuesday, Callaway Golf Co.'s stock plummeted 8.98%, closing the day at $7.60. The stock recorded a trading volume of 5.03 million shares, above its three months average volume of 1.04 million shares. The stock oscillated between $7.51 and $8.10 during the trading session. Callaway Golf Co.'s shares have declined 19.75% in the last one month and 7.54% in the past three months. Also, the stock has lost 9.85% since the start of this year. The S&P 500 Consumer Discretionary Sector Index declined 0.54% in the last one month, while the S&P 500 gained 0.43% during the same period. Callaway Golf Co.'s stock is trading below its 50-day and 200-day moving averages. The stock's 50-day moving average of $9.19 is higher than its 200-day moving average of $8.21. Moreover, shares of the company have a Relative Strength Index (RSI) of 37.06. Sign up today to read free research on ELY at:
http://www.investor-edge.com/2816-ELY-21May2014.pdf

Annaly Capital Management Inc.'s stock traded between $11.65 and $11.78 before ending the day 0.51% lower at $11.67. The company's stock reported a trading volume of 6.11 million shares on Tuesday, which was below its three months average volume of 10.71 million shares. Over the last one month and past three months, Annaly Capital Management Inc.'s stock has gained 3.73% and 7.56%, respectively. Also, the stock has surged 17.05% since start of this year. The S&P 500 Financials Sector Index lost 0.76% in the last one month, while the NASDAQ Composite Index has gained 0.03% during the same period. The stock is trading above its 50-day and 200-day moving averages. Annaly Capital Management Inc's 50-day moving average of $11.36 is greater than its 200-day moving average of $11.10. Additionally, the company's stock traded at a PE ratio of 5.69 and has an RSI of 58.92. Sign up today to read free research on NLY at:
http://www.investor-edge.com/2816-NLY-21May2014.pdf

On Tuesday, shares in Weatherford International Ltd recorded a trading volume of 7.76 million shares, which was below its three months average volume of 9.29 million shares. The stock finished the day at $21.02, which was 0.72% higher to its previous day's closing, and registered an intraday range of $20.63 and $21.07. Weatherford International Ltd's shares have rallied 15.43% in the last one month and 38.84% in the past three months. Also, the stock has surged 35.70% on YTD basis. The S&P 500 Energy Sector Index advanced 0.35% in the last one month, while the S&P 500 gained 0.43% during the same period. Weatherford International Ltd's stock is trading above its 50-day and 200-day moving averages; while, the 50-day moving average of $18.47 is above its 200-day moving average of $16.11. Furthermore, shares of the company traded at a PE ratio of 36.24 and have an RSI of 63.90. Sign up today to read free research on WFT at:
http://www.investor-edge.com/2816-WFT-21May2014.pdf

Shares in Chelsea Therapeutics International Ltd closed Tuesday's session 0.15% lower at an intra-day low of $6.53. A total of 5.55 million shares were traded, which was above its three months average volume of 5.08 million shares. The stock moved between $6.53 and $6.58 during the session. Over the last one month and previous three months, shares in Chelsea Therapeutics International Ltd have advanced 38.05% and 9.75%, respectively. Also, the company's stock has gone up 47.24% since the beginning of 2014. The S&P 500 Health Care Sector Index advanced 2.04% in the last one month, while the NASDAQ Composite Index gained 0.03% during the same period. The company's shares are trading above their 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $5.55 is greater than its 200-day moving average of $4.13. Further, Chelsea Therapeutics International Ltd's stock has an RSI of 70.15. Sign up today to read free research on CHTP at:
http://www.investor-edge.com/2816-CHTP-21May2014.pdf

===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED